AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Genenta Science S.p.A. American Depositary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG013GNLKF0
0.63▼ 0.00 (-0.01%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
0.63
Day's Range
0.63 – 0.64
52-Week Range
0.55 – 10.00
Volume
13.4K
Avg Volume
59.1K
Share Statistics
Shares Outstanding
Employees
9
Exchange
XNAS
Listed
2021-12-15
Share count as of December 31, 2025

Genenta Science S.p.A. American Depositary Shares (GNTA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Genenta Science S.p.A. American Depositary Shares (GNTA)
What is Genenta Science S.p.A. American Depositary Shares's Market Cap?
Genenta Science S.p.A. American Depositary Shares's Market Cap is $14.8M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · GNTAAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Operating expenses
Total
General and Administrative Expense
Total operating expenses
Loss from operations
Other income (expense)
Non-Operating Income (Expense)
Finance income
Total other income, net
Loss before income taxes
Net loss
Earnings Per Share (Diluted)